SKK
Shepherd Kaplan Krochuk Portfolio holdings
AUM
$115M
This Quarter Return
-1.9%
1 Year Return
+8.7%
3 Year Return
+33.05%
5 Year Return
+89.56%
10 Year Return
+369.71%
AUM
$143M
AUM Growth
+$143M
(-2.8%)
Cap. Flow
+$1.61M
Cap. Flow
% of AUM
1.12%
Top 10 Holdings %
Top 10 Hldgs %
24.05%
Holding
289
New
41
Increased
43
Reduced
50
Closed
40
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$1.27M |
| 2 |
HPR
HighPoint Resources Corporation
HPR
|
$1.12M |
| 3 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
$881K |
| 4 |
PE
PARSLEY ENERGY INC
PE
|
$878K |
| 5 |
Nutrien
NTR
|
$776K |
Top Sells
| 1 |
iShares Russell 2000 Value ETF
IWN
|
$2.07M |
| 2 |
BBG
Bill Barrett Corp
BBG
|
$1.21M |
| 3 |
Coterra Energy
CTRA
|
$922K |
| 4 |
AGU
Agrium
AGU
|
$847K |
| 5 |
EQT Corp
EQT
|
$813K |
Sector Composition
| 1 | Energy | 18.99% |
| 2 | Financials | 15.39% |
| 3 | Healthcare | 11.14% |
| 4 | Industrials | 9.71% |
| 5 | Materials | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Neurocrine Biosciences
NBIX
$13.8B
| – | – | -4,094 | Closed | -$318K |
|
277
Noodles & Co
NDLS
$33.1M
| – | – | -10,000 | Closed | -$53K |
|
278
Novartis
NVS
$245B
| – | – | 0 | – | – |
|
279
Pfizer
PFE
$141B
| – | – | 0 | – | – |
|
280
Invesco QQQ Trust
QQQ
$364B
| – | – | 0 | – | – |
|
281
Schwab Short-Term US Treasury ETF
SCHO
$11.7B
| – | – | -10,500 | Closed | -$525K |
|
282
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| – | – | -4,800 | Closed | -$402K |
|
283
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
284
Taylor Devices
TAYD
$154M
| – | – | -12,000 | Closed | -$161K |
|
285
Tempest Therapeutics
TPST
$44M
| – | – | -20,000 | Closed | -$28K |
|
286
ProShares UltraPro QQQ
TQQQ
$26B
| – | – | 0 | – | – |
|
|
TRIB
287
Trinity Biotech
TRIB
$5.44M
| – | – | -36,400 | Closed | -$186K |
|
|
JASN
288
DELISTED
Jason Industries, Inc.
JASN
| – | – | -12,500 | Closed | -$30K |
|